SCM
ALXN
Soleus Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-25,318
| Closed | -$3.87M | – | 90 |
|
|
2021
Q1 | $3.87M | Buy |
25,318
+6,380
| +34% | +$975K | 0.7% | 26 |
|
|
2020
Q4 | $2.96M | Sell |
18,938
-11,139
| -37% | -$1.74M | 0.39% | 27 |
|
|
2020
Q3 | $3.44M | Sell |
30,077
-20,712
| -41% | -$2.37M | 1.82% | 22 |
|
|
2020
Q2 | $5.7M | Buy |
50,789
+2,989
| +6% | +$335K | 3.25% | 8 |
|
|
2020
Q1 | $4.29M | Buy |
47,800
+16,500
| +53% | +$1.48M | 4.99% | 6 |
|
|
2019
Q4 | $3.39M | Buy |
+31,300
| New | +$3.39M | 3.26% | 9 |
|